Biotechs Hope to Develop Next-Gen CRISPR Gene Editing in 2022
"The era of CRISPR is just beginning," said Benjamin Oakes, the CEO of the gene-editing startup Scribe Therapeutics.
Source: businessinsider.com
📰 Code Therapeutics News
Page 11 - Code Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Code Therapeutics. Real-time updates on events, politics, business and more.
TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference
07.12.2021 - BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the MedInvest Oncology Investor Conference. TransCode’s Chief Executive Officer, Michael Dudley, will ...
Exchange Commission Transcode Therapeutics Inc Private Securities Litigation Reform Act Quarterly Report Code Therapeutics
Source: wallstreet-online.de
Marketing Agency Swaps North Dallas Space for Downtown's One Main Place
Plus Smoothie King CEO launches new Asian concept; Rosewood Property Company and Champion Partners started construction on South Dallas industrial; and more.
Source: dmagazine.com
ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs
ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.
United States David Lockhart Vertex Pharmaceuticals Hunt Technology Ventures Alnylam Pharmaceuticals Osage University Partners
Source: medcitynews.com
ReCode Therapeutics Presents Preclinical Data Using SORT-LNP™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--Jun 11, 2021--
United States Michael Torres David Lockhart Sarah Mccabe Recode Therapeutics The Company Canale Communications Inc
Source: manchestertimes.com
TransCode Therapeutics Announces Key Appointments
Share: Industry Experts Provide Added Depth to Board of Directors and Advisory Board TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory Board. Philippe Calais, Pharm D, Ph.D., President, Chief Executive Officer and a director of MatriSys Bioscience, Inc., has been elected Chairman of the Board of Directors of TransCode. Dr. Calais has served on ...
Erik Manting Lubomir Nechev Philippe Calais Magda Marquet Board Of Directors Matrisys Bioscience Inc Analytical Sciences At Alnylam Pharmaceuticals Inc
Source: benzinga.com